Total Payments
$6,737
2024 Payments
$1,795
Companies
26
Transactions
312
Medicare Patients
3,801
Medicare Billing
$238,545
Payment Breakdown by Category
Food & Beverage$6,382 (94.7%)
Education$354.99 (5.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,382 | 307 | 94.7% |
| Education | $354.99 | 5 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,892 | 106 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $780.06 | 28 | $0 (2024) |
| Lilly USA, LLC | $749.39 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $630.81 | 30 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $335.45 | 14 | $0 (2024) |
| LEO Pharma Inc. | $316.66 | 14 | $0 (2024) |
| Amgen Inc. | $301.98 | 14 | $0 (2024) |
| PFIZER INC. | $297.18 | 14 | $0 (2024) |
| UCB, Inc. | $251.55 | 12 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $198.18 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,795 | 75 | ABBVIE INC. ($462.13) |
| 2023 | $2,134 | 88 | E.R. Squibb & Sons, L.L.C. ($423.12) |
| 2022 | $1,535 | 74 | ABBVIE INC. ($514.15) |
| 2021 | $1,272 | 75 | AbbVie Inc. ($528.14) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.56 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.56 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.08 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.27 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 11/15/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Immunology | ||||||
| 10/30/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Inflammation & Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.34 | General |
| 09/18/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Obesity | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.28 | General |
| Category: Immunology | ||||||
| 09/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 728 | 1,186 | $129,620 | $46,107 |
| 2022 | 12 | 859 | 1,642 | $150,233 | $51,244 |
| 2021 | 15 | 1,208 | 2,090 | $205,204 | $72,705 |
| 2020 | 18 | 1,006 | 1,719 | $206,796 | $68,489 |
Total Patients
3,801
Total Services
6,637
Medicare Billing
$238,545
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 247 | $33,840 | $13,201 | 39.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 44 | 44 | $20,671 | $8,153 | 39.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 75 | 86 | $13,547 | $4,785 | 35.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 120 | 140 | $14,475 | $4,260 | 29.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 58 | 62 | $10,928 | $4,199 | 38.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 93 | 451 | $4,690 | $1,949 | 41.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $4,408 | $1,734 | 39.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 16 | 17 | $4,434 | $1,728 | 39.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $5,658 | $1,257 | 22.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 13 | $5,577 | $1,239 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 34 | $2,926 | $1,080 | 36.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 16 | $4,242 | $942.56 | 22.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 13 | $2,512 | $819.21 | 32.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 22 | $1,713 | $761.02 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 252 | $30,966 | $11,964 | 38.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 36 | 40 | $18,523 | $8,097 | 43.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 106 | 121 | $21,080 | $6,597 | 31.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 170 | 200 | $22,887 | $5,779 | 25.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 57 | 62 | $10,837 | $3,982 | 36.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 133 | 781 | $11,868 | $3,281 | 27.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 23 | 28 | $7,286 | $2,561 | 35.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2022 | 18 | 24 | $10,314 | $2,487 | 24.1% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2022 | 11 | 11 | $4,300 | $1,930 | 44.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 47 | 53 | $3,955 | $1,614 | 40.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $4,134 | $1,478 | 35.7% |
About Daniel Rhoads, PAC
Daniel Rhoads, PAC is a Physician Assistant healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316046162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Rhoads, PAC has received a total of $6,737 in payments from pharmaceutical and medical device companies, with $1,795 received in 2024. These payments were reported across 312 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,382).
As a Medicare-enrolled provider, Rhoads has provided services to 3,801 Medicare beneficiaries, totaling 6,637 services with total Medicare billing of $238,545. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Spokane, WA
- Active Since 09/21/2006
- Last Updated 04/18/2012
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1316046162
Products in Payments
- SKYRIZI (Biological) $1,182
- Sotyktu (Drug) $780.06
- TREMFYA (Drug) $515.33
- RINVOQ (Biological) $465.55
- TALTZ (Drug) $441.28
- ADBRY (Biological) $316.66
- Otezla (Drug) $301.98
- CIBINQO (Drug) $237.25
- DUPIXENT (Biological) $216.90
- HUMIRA (Biological) $210.29
- OLUMIANT (Drug) $183.12
- REMICADE (Biological) $161.03
- Cimzia (Drug) $146.93
- ZEPBOUND (Drug) $124.99
- SPEVIGO (Drug) $102.49
- ILUMYA (Biological) $91.95
- AMELUZ (Drug) $88.47
- COSENTYX (Biological) $81.87
- Bimzelx (Biological) $81.52
- SILIQ (Drug) $79.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Spokane
Jeremy Brett, Pa, PA
Physician Assistant — Payments: $16,008
Physician Assistant $16,008
Kristine Wessels
Physician Assistant — Payments: $9,192
Physician Assistant $9,192
Lori Tschetter, Pa-C, PA-C
Physician Assistant — Payments: $6,771
Physician Assistant $6,771
Gareth Olstad, Pa-C, PA-C
Physician Assistant — Payments: $6,570
Physician Assistant $6,570
Trent Lengl, Pa-C, PA-C
Physician Assistant — Payments: $5,456
Physician Assistant $5,456
Brandy Manchester, Pa, PA
Physician Assistant — Payments: $4,160
Physician Assistant $4,160